Used in research for cancer immunotherapy, particularly in modulating immune responses through targeting specific signaling pathways in tumor-associated macrophages. Shows potential in enhancing anti-tumor activity by reprogramming the tumor microenvironment. Investigated for its role in combination therapies with checkpoint inhibitors to improve treatment efficacy in solid tumors. Still under preclinical and early clinical evaluation, not approved for commercial therapeutic use.